,Set,NGenes,Direction,PValue,FDR
1,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,3.39491640660376e-11,2.79062128622829e-08
2,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.000442985125066183,0.135596366912701
3,WP_PROSTAGLANDIN_SIGNALING,20,Up,0.000540106590342643,0.135596366912701
4,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,35,Up,0.000794712899237134,0.135596366912701
5,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Up,0.000824795419177011,0.135596366912701
6,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Up,0.00107654481097678,0.142154341176739
7,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Up,0.0012105600830136,0.142154341176739
8,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.0015389589545555,0.151392542490272
9,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.00165758258201028,0.151392542490272
10,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.00222604294179423,0.154668965783193
11,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.00257659089656671,0.154668965783193
12,WP_BENZENE_METABOLISM,3,Up,0.0025771260108358,0.154668965783193
13,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.00258017004875377,0.154668965783193
14,WP_NRF2_PATHWAY,67,Up,0.00267727981183387,0.154668965783193
15,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.00282242638290498,0.154668965783193
16,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.00453029481306884,0.232743896021412
17,WP_SYNAPTIC_VESICLE_PATHWAY,19,Up,0.005033166127929,0.243368385715155
18,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Up,0.0055097766988242,0.251613135912972
19,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.00684867895027389,0.28881388952338
20,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.00702710193487543,0.28881388952338
21,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,71,Up,0.00785965191582255,0.299542599078965
22,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Down,0.00801695520649299,0.299542599078965
23,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.00842830740354404,0.301220377639705
24,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Up,0.00880051204334232,0.301417537484475
25,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Up,0.00921126181861752,0.302866288596144
26,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.0100576020864265,0.315351376946526
27,WP_MEVALONATE_PATHWAY,7,Up,0.0103582569070027,0.315351376946526
28,WP_CORI_CYCLE,11,Up,0.0118653602200087,0.348333075030256
29,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.0123722767441033,0.350690051160446
30,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.0135623439444878,0.354930288514343
31,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Up,0.0138889241120977,0.354930288514343
32,WP_AEROBIC_GLYCOLYSIS,10,Up,0.0142490261812328,0.354930288514343
33,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.0142490261812328,0.354930288514343
34,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.0147746848322344,0.357199733296961
35,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.0156328156135141,0.360236555739896
36,WP_DOPAMINE_METABOLISM,7,Up,0.0157767834630612,0.360236555739896
37,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Down,0.0184226627831674,0.409281859669287
38,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.0189215202567771,0.409302359238704
39,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.0195997205584907,0.410231985039631
40,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.0205069579130275,0.410231985039631
41,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.0206195483576645,0.410231985039631
42,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.0209771895424009,0.410231985039631
43,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.0214598240349199,0.410231985039631
44,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Up,0.0226791936836912,0.420227028829853
45,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.0230051293155029,0.420227028829853
46,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.0252733570136458,0.451623901417757
47,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,59,Up,0.027051054354401,0.473105674028034
48,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.0285568296140508,0.477546560367752
49,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.0290478443046078,0.477546560367752
50,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.0290478443046078,0.477546560367752
51,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Up,0.0305047870130221,0.491665390680474
52,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Up,0.0330910973744477,0.523093885419154
53,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.0343632115090532,0.524015348385118
54,WP_SILDENAFIL_TREATMENT,10,Down,0.0350116041715992,0.524015348385118
55,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.0350618542106831,0.524015348385118
56,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.0362278378225626,0.530819904487457
57,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.0368086795082543,0.530819904487457
58,WP_ZINC_HOMEOSTASIS,21,Up,0.038949541013095,0.539646974990982
59,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.0391641893107689,0.539646974990982
60,WP_LUNG_FIBROSIS,30,Up,0.0397683079995986,0.539646974990982
61,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Up,0.0407734295100137,0.539646974990982
62,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.0413127676276105,0.539646974990982
63,WP_SPINAL_CORD_INJURY,63,Up,0.0413598046525935,0.539646974990982
64,WP_VITAMIN_D_METABOLISM,6,Up,0.0435885225056427,0.554048459096694
65,WP_BURN_WOUND_HEALING,59,Up,0.0438116178117824,0.554048459096694
66,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.0462956770662003,0.57659161436995
67,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.0495744741277056,0.608212204969761
68,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Down,0.0534854114431392,0.632103419820322
69,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.0535557642549329,0.632103419820322
70,WP_MTHFR_DEFICIENCY,18,Up,0.0538287583788595,0.632103419820322
71,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.0566943204481571,0.653945152016418
72,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.0572798673299053,0.653945152016418
73,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Up,0.0581740425764724,0.655055657504936
74,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,11,Up,0.0612258637137182,0.672178464480395
75,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,19,Up,0.0622685051432669,0.672178464480395
76,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.0626199754794739,0.672178464480395
77,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.064347369993389,0.672178464480395
78,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.0644907053697667,0.672178464480395
79,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,17,Down,0.0683576161904209,0.672178464480395
80,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.0688899910995701,0.672178464480395
81,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Down,0.0692372893773686,0.672178464480395
82,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Down,0.0692372893773686,0.672178464480395
83,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.0696187316339563,0.672178464480395
84,WP_NUCLEAR_RECEPTORS_METAPATHWAY,171,Up,0.0700024215135725,0.672178464480395
85,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Down,0.0700633611658069,0.672178464480395
86,WP_APOPTOSIS_MODULATION_AND_SIGNALING,75,Down,0.0703252408093844,0.672178464480395
87,WP_CILIARY_LANDSCAPE,183,Up,0.0714687586156739,0.675256546920506
88,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.0728870759017334,0.680831549900282
89,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.0746115723455558,0.689109128854459
90,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.0759456608913937,0.693637036141395
91,WP_SMALL_LIGAND_GPCRS,7,Up,0.0794418699140592,0.717595791970953
92,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.0811132611401142,0.724729354969281
93,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.0827313718823288,0.731238577282519
94,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.0854595786642509,0.733465766615815
95,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.0854766643072839,0.733465766615815
96,WP_FOXA2_PATHWAY,9,Down,0.0868100785679949,0.733465766615815
97,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Up,0.0899877895837963,0.733465766615815
98,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.0900639767999653,0.733465766615815
99,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Up,0.0908786469744248,0.733465766615815
100,WP_FERROPTOSIS,50,Up,0.091284000664606,0.733465766615815
101,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.0921017763666331,0.733465766615815
102,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.0932829093420769,0.733465766615815
103,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.0937971464734735,0.733465766615815
104,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.0955029615349413,0.733465766615815
105,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Up,0.0985893517780782,0.733465766615815
106,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.0987384001990916,0.733465766615815
107,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Up,0.100692510779482,0.733465766615815
108,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Down,0.101538302572232,0.733465766615815
109,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.10311964837401,0.733465766615815
110,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.103325445814848,0.733465766615815
111,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.104010907570198,0.733465766615815
112,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Up,0.104146558449648,0.733465766615815
113,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Up,0.104642466534144,0.733465766615815
114,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Down,0.104778889527016,0.733465766615815
115,WP_DOPAMINERGIC_NEUROGENESIS,4,Up,0.104819249126131,0.733465766615815
116,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.107777644711331,0.733465766615815
117,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.108899910472309,0.733465766615815
118,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,82,Up,0.109529675201436,0.733465766615815
119,WP_ATR_SIGNALING,10,Up,0.109738967045353,0.733465766615815
120,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.110991391112648,0.733465766615815
121,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.112300736400106,0.733465766615815
122,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Up,0.112844180363727,0.733465766615815
123,WP_MONOAMINE_GPCRS,3,Up,0.113888443146885,0.733465766615815
124,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.115863336995171,0.733465766615815
125,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.115863336995171,0.733465766615815
126,WP_HYPERTROPHY_MODEL,12,Up,0.115895931205062,0.733465766615815
127,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.117353885726049,0.733465766615815
128,WP_ALPHA_6_BETA_4_SIGNALING,25,Down,0.117990180160031,0.733465766615815
129,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.118075717656129,0.733465766615815
130,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.118220306332491,0.733465766615815
131,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.11995339067101,0.733465766615815
132,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Down,0.121254579755569,0.733465766615815
133,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.121693274585627,0.733465766615815
134,WP_NGLYCAN_BIOSYNTHESIS,51,Up,0.121911009664505,0.733465766615815
135,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.123435018317554,0.733465766615815
136,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.124601534239129,0.733465766615815
137,WP_AXON_GUIDANCE,35,Up,0.124618594441317,0.733465766615815
138,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Down,0.12465480236657,0.733465766615815
139,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.128167083472208,0.733465766615815
140,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.128573778757012,0.733465766615815
141,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.12869737118603,0.733465766615815
142,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,88,Up,0.131989570511038,0.733465766615815
143,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.132069048472618,0.733465766615815
144,WP_ONECARBON_METABOLISM,22,Up,0.133467408288289,0.733465766615815
145,WP_GLUCURONIDATION,7,Up,0.134802495852965,0.733465766615815
146,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.135386682296227,0.733465766615815
147,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Up,0.135758552182545,0.733465766615815
148,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.137975866103616,0.733465766615815
149,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.138067027244589,0.733465766615815
150,WP_COMPLEMENT_ACTIVATION,11,Down,0.138823989208004,0.733465766615815
151,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.139430666779252,0.733465766615815
152,WP_SLEEP_REGULATION,10,Down,0.139656569851908,0.733465766615815
153,WP_TP53_NETWORK,16,Down,0.141695712762957,0.733465766615815
154,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.141896491038819,0.733465766615815
155,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,125,Up,0.142919552970143,0.733465766615815
156,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Up,0.143061820032337,0.733465766615815
157,WP_MACROPHAGE_MARKERS,8,Down,0.143643606638143,0.733465766615815
158,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.144248543308523,0.733465766615815
159,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.145963661369673,0.733465766615815
160,WP_VEGFAVEGFR2_SIGNALING,333,Up,0.146690655261887,0.733465766615815
161,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Up,0.147704548194902,0.733465766615815
162,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.14856749991499,0.733465766615815
163,WP_CELL_CYCLE,90,Up,0.149805275326422,0.733465766615815
164,WP_PDGF_PATHWAY,35,Up,0.150717206284026,0.733465766615815
165,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.151146074485137,0.733465766615815
166,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Up,0.151462905761724,0.733465766615815
167,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.151780145331855,0.733465766615815
168,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.151793638225107,0.733465766615815
169,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.152573233964199,0.733465766615815
170,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,50,Down,0.154461332968059,0.733465766615815
171,WP_KREBS_CYCLE_DISORDERS,11,Up,0.154791382227244,0.733465766615815
172,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.154810488535255,0.733465766615815
173,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Down,0.156031832909215,0.733465766615815
174,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.156064998486121,0.733465766615815
175,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.156225775280459,0.733465766615815
176,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.157043765114822,0.733465766615815
177,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Up,0.158550137580242,0.736317588084512
178,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.16163000704161,0.746403740383167
179,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.16389339580844,0.75005807329464
180,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.164246293422184,0.75005807329464
181,WP_SPHINGOLIPID_PATHWAY,19,Up,0.165861955704421,0.753251533641073
182,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.168438755224632,0.753965794142602
183,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.170040657506808,0.753965794142602
184,WP_AUTOPHAGY,27,Down,0.171179789864941,0.753965794142602
185,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.172393073844487,0.753965794142602
186,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.172646583157792,0.753965794142602
187,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.172707381783134,0.753965794142602
188,WP_GLUCOCORTICOID_BIOSYNTHESIS,5,Up,0.174779300970266,0.753965794142602
189,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.175242445427114,0.753965794142602
190,WP_OSTEOBLAST_SIGNALING,2,Down,0.176931397209304,0.753965794142602
191,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.178170401760341,0.753965794142602
192,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.178599617243679,0.753965794142602
193,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.178913484914191,0.753965794142602
194,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.17898871778075,0.753965794142602
195,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.178988914357871,0.753965794142602
196,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.179777731936679,0.753965794142602
197,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.180806720946263,0.754432104659025
198,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.184213330942396,0.759172856571363
199,WP_POSTCOVID_NEUROINFLAMMATION,11,Up,0.184219933879739,0.759172856571363
200,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.185764972670467,0.759172856571363
201,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.186104756124985,0.759172856571363
202,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,56,Up,0.187543347906505,0.759172856571363
203,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.188217680628269,0.759172856571363
204,WP_TYPE_II_DIABETES_MELLITUS,13,Down,0.189386903029199,0.759172856571363
205,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.190757787172165,0.759172856571363
206,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.192383872497123,0.759172856571363
207,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Down,0.192987451360121,0.759172856571363
208,WP_CREATINE_PATHWAY,2,Down,0.193308385377587,0.759172856571363
209,WP_KLEEFSTRA_SYNDROME,24,Down,0.193634313001989,0.759172856571363
210,WP_KIT_RECEPTOR_SIGNALING,50,Down,0.193949269926991,0.759172856571363
211,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,40,Up,0.196020712470451,0.760126275766473
212,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.196213157091606,0.760126275766473
213,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.196967027662115,0.760126275766473
214,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.200829691068376,0.767400396853312
215,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.200932104186404,0.767400396853312
216,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.201993603545853,0.767400396853312
217,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.202586236152273,0.767400396853312
218,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.205659183018573,0.770640785357254
219,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.205938896901037,0.770640785357254
220,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.208012009095681,0.770640785357254
221,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,34,Down,0.20808090169537,0.770640785357254
222,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.20883429821197,0.770640785357254
223,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,0.209066782402272,0.770640785357254
224,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.212123704171014,0.776216851621249
225,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,76,Up,0.213196472361954,0.776216851621249
226,WP_MATRIX_METALLOPROTEINASES,8,Up,0.213618368713701,0.776216851621249
227,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Up,0.214356721798082,0.776216851621249
228,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,68,Up,0.216180143268396,0.777206833226783
229,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.216521125071695,0.777206833226783
230,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Up,0.218980623324301,0.781597401328489
231,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.220500252318191,0.781597401328489
232,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Down,0.220924584605353,0.781597401328489
233,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.222777094480959,0.781597401328489
234,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Down,0.223752313139432,0.781597401328489
235,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Up,0.223856778000567,0.781597401328489
236,WP_PROTEASOME_DEGRADATION,57,Up,0.224400227145406,0.781597401328489
237,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.22680741477038,0.782234718300104
238,WP_IL19_SIGNALING,20,Up,0.227619931956535,0.782234718300104
239,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.228462835085662,0.782234718300104
240,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.229529607546363,0.782234718300104
241,WP_MESODERMAL_COMMITMENT_PATHWAY,75,Down,0.229763021992462,0.782234718300104
242,WP_EGFEGFR_SIGNALING,136,Up,0.230292946263534,0.782234718300104
243,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.23227870573061,0.782500183438849
244,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.234327589642814,0.782500183438849
245,WP_BDNFTRKB_SIGNALING,26,Up,0.235483527640009,0.782500183438849
246,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.235980837590689,0.782500183438849
247,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.236744219444298,0.782500183438849
248,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.23684409784406,0.782500183438849
249,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Up,0.237034727100089,0.782500183438849
250,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.242356222330944,0.796364844676854
251,WP_RETINOBLASTOMA_GENE_IN_CANCER,66,Up,0.243431086974071,0.796364844676854
252,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.244141047273196,0.796364844676854
253,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Up,0.246442450210282,0.800694442975697
254,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.249102191518011,0.800774239317723
255,WP_AMINO_ACID_METABOLISM,58,Up,0.249754547630771,0.800774239317723
256,WP_NUCLEOTIDE_GPCRS,5,Down,0.249933926928581,0.800774239317723
257,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.250363722025127,0.800774239317723
258,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.253495158336914,0.803989097067944
259,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.253893751526699,0.803989097067944
260,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Up,0.25492815091954,0.803989097067944
261,WP_FOCAL_ADHESION,114,Up,0.25528497160951,0.803989097067944
262,WP_G1_TO_S_CELL_CYCLE_CONTROL,49,Up,0.25720915237172,0.803989097067944
263,WP_GPR40_PATHWAY,7,Down,0.257237387504707,0.803989097067944
264,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.260385352151622,0.81074530101755
265,WP_G13_SIGNALING,29,Up,0.2637204587536,0.815725034386566
266,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.264524429046295,0.815725034386566
267,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.264961781242352,0.815725034386566
268,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.268647301519537,0.820826017482561
269,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Up,0.271483367851714,0.820826017482561
270,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Up,0.271727505892906,0.820826017482561
271,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.271910175540928,0.820826017482561
272,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.272216163490947,0.820826017482561
273,WP_CAMKK2_PATHWAY,29,Up,0.272610100696763,0.820826017482561
274,WP_ARYLAMINE_METABOLISM,1,Up,0.275773318081865,0.822398612923311
275,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.276953962834403,0.822398612923311
276,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Up,0.277116431479978,0.822398612923311
277,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Down,0.280632107361782,0.822398612923311
278,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.281216230807669,0.822398612923311
279,WP_RAC1PAK1P38MMP2_PATHWAY,51,Up,0.282623400434717,0.822398612923311
280,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,36,Up,0.285329786381419,0.822398612923311
281,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.285594469819418,0.822398612923311
282,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.285897956046552,0.822398612923311
283,WP_MAPK_SIGNALING,156,Up,0.288763993543362,0.822398612923311
284,WP_HISTONE_MODIFICATIONS,36,Down,0.289650527894237,0.822398612923311
285,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.290808849111207,0.822398612923311
286,WP_APOPTOSIS,70,Down,0.290945275277655,0.822398612923311
287,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.293661993777611,0.822398612923311
288,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Up,0.294989183147609,0.822398612923311
289,WP_INTEGRATED_CANCER_PATHWAY,39,Down,0.296351760885683,0.822398612923311
290,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,38,Up,0.296819683365593,0.822398612923311
291,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Up,0.297493442605727,0.822398612923311
292,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.297578485702629,0.822398612923311
293,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.299323710907258,0.822398612923311
294,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.300564222815819,0.822398612923311
295,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Up,0.30151253875178,0.822398612923311
296,WP_NOTCH_SIGNALING_WP268,34,Up,0.302008399647549,0.822398612923311
297,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.302348811229152,0.822398612923311
298,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.303283099252993,0.822398612923311
299,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.303354611772519,0.822398612923311
300,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Up,0.304897952124043,0.822398612923311
301,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.305476820167914,0.822398612923311
302,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.306468243071452,0.822398612923311
303,WP_IL6_SIGNALING,38,Up,0.306485322827448,0.822398612923311
304,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.307645484343732,0.822398612923311
305,WP_SPINA_BIFIDA,10,Up,0.308814575062147,0.822398612923311
306,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Down,0.309808874202433,0.822398612923311
307,WP_GASTRIC_CANCER_NETWORK_2,24,Down,0.310909994973386,0.822398612923311
308,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Up,0.312366297399821,0.822398612923311
309,WP_IRINOTECAN_PATHWAY,5,Up,0.312717267492931,0.822398612923311
310,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.314587145947673,0.822398612923311
311,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.31592050848892,0.822398612923311
312,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.315930831256301,0.822398612923311
313,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.317851804057083,0.822398612923311
314,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Down,0.319691860321139,0.822398612923311
315,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.320964898395433,0.822398612923311
316,WP_RETT_SYNDROME,31,Down,0.321009135068433,0.822398612923311
317,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.321098980633531,0.822398612923311
318,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.321544228261368,0.822398612923311
319,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.325031532024967,0.822398612923311
320,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.325466904479439,0.822398612923311
321,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Down,0.326804536304169,0.822398612923311
322,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Down,0.326869904759343,0.822398612923311
323,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Up,0.327777786391696,0.822398612923311
324,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.328199900289746,0.822398612923311
325,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.3288072326891,0.822398612923311
326,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.329070528742366,0.822398612923311
327,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.329326256329339,0.822398612923311
328,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.330213312830567,0.822398612923311
329,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.33072242099761,0.822398612923311
330,WP_LEPTIN_SIGNALING,69,Down,0.332038525850062,0.822398612923311
331,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.332247179779138,0.822398612923311
332,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.332750631742599,0.822398612923311
333,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.333599544454266,0.822398612923311
334,WP_NEPHROGENESIS,4,Down,0.334761148460619,0.822398612923311
335,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,70,Up,0.335761449436783,0.822398612923311
336,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.336162936669382,0.822398612923311
337,WP_GLUTATHIONE_METABOLISM,10,Up,0.339383926224939,0.826418738349807
338,WP_DNA_MISMATCH_REPAIR,21,Down,0.339816950805638,0.826418738349807
339,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.342069463215039,0.82766996848349
340,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.343218757332152,0.82766996848349
341,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.34350732671404,0.82766996848349
342,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.34538286551172,0.82766996848349
343,WP_OPIOID_RECEPTOR_PATHWAYS,24,Up,0.345395306723252,0.82766996848349
344,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.349101537237468,0.82766996848349
345,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.349622690015803,0.82766996848349
346,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.349622690015803,0.82766996848349
347,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.351162630832869,0.82766996848349
348,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.351756916616327,0.82766996848349
349,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.35228442364182,0.82766996848349
350,WP_MINERALOCORTICOID_BIOSYNTHESIS,4,Up,0.353300705150664,0.82766996848349
351,WP_SMALL_CELL_LUNG_CANCER,67,Down,0.353421117929081,0.82766996848349
352,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.3568697488416,0.829702329025499
353,WP_ERBB_SIGNALING,67,Down,0.357043288417311,0.829702329025499
354,WP_PURINERGIC_SIGNALING,14,Up,0.359070765787828,0.829702329025499
355,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Up,0.359531667625087,0.829702329025499
356,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.361964529749899,0.829702329025499
357,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Up,0.362776280400093,0.829702329025499
358,WP_BENZOAPYRENE_METABOLISM,5,Up,0.365441973433878,0.829702329025499
359,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.3658168909179,0.829702329025499
360,WP_BLADDER_CANCER,28,Up,0.366291377057579,0.829702329025499
361,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.367010815098613,0.829702329025499
362,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Up,0.36769247537401,0.829702329025499
363,WP_NRF2ARE_REGULATION,20,Up,0.368192414993701,0.829702329025499
364,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.369039979904555,0.829702329025499
365,WP_GPCRS_OTHER,11,Down,0.369591884259835,0.829702329025499
366,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Down,0.369702403597135,0.829702329025499
367,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.370575396108876,0.829702329025499
368,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.371859471626293,0.829702329025499
369,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.372457614854512,0.829702329025499
370,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.3752180656957,0.829987653963192
371,WP_WNT_SIGNALING_WP363,37,Up,0.375550396114218,0.829987653963192
372,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.376981018852318,0.829987653963192
373,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.378393504311647,0.829987653963192
374,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.379012710778632,0.829987653963192
375,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.379048116612492,0.829987653963192
376,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.380456818500914,0.829987653963192
377,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.38066343740161,0.829987653963192
378,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.38374414625678,0.832943117339309
379,WP_GPCRS_CLASS_B_SECRETINLIKE,3,Down,0.384045549235521,0.832943117339309
380,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,45,Up,0.385742336100881,0.834380364115664
381,WP_KININKALLIKREIN_PATHWAY,2,Up,0.387172176828499,0.834380364115664
382,WP_TNFALPHA_SIGNALING,82,Up,0.387753405221634,0.834380364115664
383,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.392772824374201,0.841310723123017
384,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.3930210677363,0.841310723123017
385,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,268,Up,0.396591220109927,0.842611055889613
386,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Up,0.398270463533227,0.842611055889613
387,WP_TRYPTOPHAN_METABOLISM,18,Up,0.399118838222108,0.842611055889613
388,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.399652008334167,0.842611055889613
389,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.399715999627817,0.842611055889613
390,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.399778968122809,0.842611055889613
391,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,47,Up,0.402586477569924,0.843251705778573
392,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,130,Up,0.40294996760609,0.843251705778573
393,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.403160487069318,0.843251705778573
394,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.406786337058514,0.847382643108718
395,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Up,0.407197255508447,0.847382643108718
396,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.409825861246042,0.850699136222844
397,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,20,Down,0.41112954466773,0.851158827341633
398,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.412118264333297,0.851158827341633
399,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.414607876884866,0.852079658812135
400,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.414680094320754,0.852079658812135
401,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.41912406607438,0.852079658812135
402,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.420219309862325,0.852079658812135
403,WP_TYPE_II_INTERFERON_SIGNALING,29,Up,0.421094558257449,0.852079658812135
404,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.421172071492841,0.852079658812135
405,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,68,Up,0.423117485130481,0.852079658812135
406,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.42374060603501,0.852079658812135
407,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Up,0.425142467178875,0.852079658812135
408,WP_SEROTONIN_TRANSPORTER_ACTIVITY,3,Up,0.425745054239283,0.852079658812135
409,WP_OSTEOCLAST_SIGNALING,8,Up,0.428580725815173,0.852079658812135
410,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.4302623530214,0.852079658812135
411,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.430413791258255,0.852079658812135
412,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.430986823090889,0.852079658812135
413,WP_ANGIOGENESIS,12,Up,0.432922582013722,0.852079658812135
414,WP_RANKLRANK_SIGNALING,47,Down,0.433014090213018,0.852079658812135
415,WP_ENDOTHELIN_PATHWAYS,11,Up,0.433738663123608,0.852079658812135
416,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.435332429353352,0.852079658812135
417,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,58,Down,0.435644589879394,0.852079658812135
418,WP_CYTOSINE_METHYLATION,7,Up,0.435872324945071,0.852079658812135
419,WP_VITAMIN_B12_METABOLISM,23,Down,0.437117474539838,0.852079658812135
420,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.438273490238167,0.852079658812135
421,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.4385962694493,0.852079658812135
422,WP_IL17_SIGNALING,25,Down,0.440385877151972,0.852079658812135
423,WP_DNA_DAMAGE_RESPONSE,57,Up,0.442131387234803,0.852079658812135
424,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.442205600084663,0.852079658812135
425,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.44411536654952,0.852079658812135
426,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.444233006197467,0.852079658812135
427,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.445219188711909,0.852079658812135
428,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.445250678576833,0.852079658812135
429,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Up,0.445370771574752,0.852079658812135
430,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.445735101325083,0.852079658812135
431,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.448211130633775,0.85482494055908
432,WP_RAS_SIGNALING,113,Up,0.451152288180015,0.854921438393476
433,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.45444835035846,0.854921438393476
434,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.455196626127776,0.854921438393476
435,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.455549126713209,0.854921438393476
436,WP_HUNGER_AND_SATIETY,2,Down,0.456289354294845,0.854921438393476
437,WP_ENERGY_METABOLISM,41,Down,0.457075462462274,0.854921438393476
438,WP_GLYOXYLATE_METABOLISM,5,Up,0.458386004694329,0.854921438393476
439,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,6,Up,0.460060039915109,0.854921438393476
440,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.460901644558715,0.854921438393476
441,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,60,Up,0.46149547370382,0.854921438393476
442,WP_TAMOXIFEN_METABOLISM,2,Down,0.461824534465851,0.854921438393476
443,WP_SERINE_METABOLISM,5,Down,0.462917501073342,0.854921438393476
444,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Down,0.465970697557957,0.854921438393476
445,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.466106360861142,0.854921438393476
446,WP_CHOLESTASIS,9,Down,0.466423691850689,0.854921438393476
447,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.468500018870011,0.854921438393476
448,WP_OREXIN_RECEPTOR_PATHWAY,117,Down,0.468986687079815,0.854921438393476
449,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Down,0.469339910337663,0.854921438393476
450,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.469911459435385,0.854921438393476
451,WP_GASTRIN_SIGNALING,92,Up,0.471571040752244,0.854921438393476
452,WP_IL1_SIGNALING,51,Up,0.471927046981828,0.854921438393476
453,WP_GLIOBLASTOMA_SIGNALING,66,Down,0.472236669346525,0.854921438393476
454,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.472614612173931,0.854921438393476
455,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.473222937310258,0.854921438393476
456,WP_PPARALPHA_PATHWAY,15,Up,0.476224834444162,0.858457925248028
457,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,20,Up,0.480029400672236,0.860168479520988
458,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.480221859978215,0.860168479520988
459,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.480313056082887,0.860168479520988
460,WP_OSTEOPONTIN_SIGNALING,11,Down,0.485956427980745,0.864696713379936
461,WP_B_CELL_RECEPTOR_SIGNALING,84,Down,0.486239812903045,0.864696713379936
462,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.487110576167851,0.864696713379936
463,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Up,0.489980269245474,0.864696713379936
464,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.490415625632331,0.864696713379936
465,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Up,0.490956002545004,0.864696713379936
466,WP_PYRIMIDINE_METABOLISM,71,Down,0.4922456433887,0.864696713379936
467,WP_WNT_SIGNALING_AND_PLURIPOTENCY,59,Up,0.492820852468675,0.864696713379936
468,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.492893434028495,0.864696713379936
469,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,54,Up,0.493461289912224,0.864696713379936
470,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.495108080134685,0.864696713379936
471,WP_INSULIN_SIGNALING,129,Down,0.495464905111861,0.864696713379936
472,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Up,0.497726957722508,0.866804150948943
473,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.502361857775375,0.872412477993436
474,WP_ACE_INHIBITOR_PATHWAY,4,Up,0.504031787981244,0.872412477993436
475,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,86,Down,0.504131298110562,0.872412477993436
476,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.506419635280922,0.874531386976719
477,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.50870202748058,0.876631166853326
478,WP_INFLAMMATORY_RESPONSE_PATHWAY,12,Down,0.511435322765792,0.879497563417325
479,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Up,0.519306107203583,0.891168309230365
480,WP_ALSTROM_SYNDROME,27,Up,0.525857327390398,0.898887518980568
481,WP_METHYLATION_PATHWAYS,5,Up,0.526339400202766,0.898887518980568
482,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,83,Down,0.527084895557949,0.898887518980568
483,WP_HIPPOYAP_SIGNALING,16,Up,0.529967851988175,0.899226615267961
484,WP_JOUBERT_SYNDROME,71,Up,0.532173368472739,0.899226615267961
485,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.532534718206531,0.899226615267961
486,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.53324277364606,0.899226615267961
487,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Up,0.533431263817372,0.899226615267961
488,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.535101429431241,0.899226615267961
489,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.536574278359705,0.899226615267961
490,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.536882569134455,0.899226615267961
491,WP_ACUTE_VIRAL_MYOCARDITIS,63,Up,0.540416404808718,0.899226615267961
492,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Down,0.546004658498566,0.899226615267961
493,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.546304909812347,0.899226615267961
494,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Up,0.546449962202645,0.899226615267961
495,WP_COMPLEMENT_SYSTEM,47,Up,0.548929302297382,0.899226615267961
496,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.549410397063377,0.899226615267961
497,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.550373412636851,0.899226615267961
498,WP_HEART_DEVELOPMENT,16,Up,0.550521457976131,0.899226615267961
499,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.55139509075809,0.899226615267961
500,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.551609374037288,0.899226615267961
501,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Up,0.554488981040471,0.899226615267961
502,WP_VITAMIN_B12_DISORDERS,9,Up,0.554728717229909,0.899226615267961
503,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.557747104448664,0.899226615267961
504,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,70,Up,0.557814750664435,0.899226615267961
505,WP_ENDOMETRIAL_CANCER,49,Down,0.558096983104249,0.899226615267961
506,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.558965605103441,0.899226615267961
507,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.559519752543536,0.899226615267961
508,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.560459133405698,0.899226615267961
509,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Down,0.560478450337876,0.899226615267961
510,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,45,Up,0.561660574744897,0.899226615267961
511,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,45,Down,0.564114731684296,0.899226615267961
512,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.56567499591583,0.899226615267961
513,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Down,0.565784230766008,0.899226615267961
514,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.566105744019503,0.899226615267961
515,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.566560820663922,0.899226615267961
516,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.566786479935855,0.899226615267961
517,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.567481135918286,0.899226615267961
518,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.568517936283093,0.899226615267961
519,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.568627158177358,0.899226615267961
520,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.56911465778296,0.899226615267961
521,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.570751278951567,0.899226615267961
522,WP_VITAMIN_D_RECEPTOR_PATHWAY,82,Up,0.571041719184764,0.899226615267961
523,WP_CCL18_SIGNALING,20,Up,0.57341744561027,0.899876510274584
524,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.574748558983059,0.899876510274584
525,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.576734957056993,0.899876510274584
526,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.576789137504476,0.899876510274584
527,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.576928127633462,0.899876510274584
528,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Up,0.579500561894046,0.902177011130503
529,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.584613640632609,0.905115299473957
530,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,83,Down,0.58650197723096,0.905115299473957
531,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.586521181983811,0.905115299473957
532,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.587768379889077,0.905115299473957
533,WP_NEOVASCULARIZATION_PROCESSES,20,Down,0.588623876312766,0.905115299473957
534,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.588720428239783,0.905115299473957
535,WP_METASTATIC_BRAIN_TUMOR,5,Up,0.589095724110179,0.905115299473957
536,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.590980555883388,0.90631719577639
537,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Up,0.592994788173028,0.907335102915913
538,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.593851928672459,0.907335102915913
539,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.594963448012966,0.90734685392701
540,WP_OVARIAN_INFERTILITY,20,Up,0.597517536130848,0.909554471665847
541,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.603536303263888,0.910306765950683
542,WP_NPHP1_DELETION_SYNDROME,10,Down,0.604282493060925,0.910306765950683
543,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.604669160989818,0.910306765950683
544,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.60647314826037,0.910306765950683
545,WP_TGFBETA_RECEPTOR_SIGNALING,34,Up,0.607463715586892,0.910306765950683
546,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.608096990706831,0.910306765950683
547,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.608634590150452,0.910306765950683
548,WP_BREAST_CANCER_PATHWAY,84,Down,0.608656581916677,0.910306765950683
549,WP_NEURAL_CREST_DIFFERENTIATION,37,Up,0.609021582267949,0.910306765950683
550,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Up,0.609694166562468,0.910306765950683
551,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.611333726722353,0.910306765950683
552,WP_IL5_SIGNALING,37,Down,0.612537021956532,0.910306765950683
553,WP_ECTODERM_DIFFERENTIATION,74,Down,0.613451854830021,0.910306765950683
554,WP_IL7_SIGNALING,23,Down,0.613515752234402,0.910306765950683
555,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.616612711393495,0.912012266312541
556,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.618494432219233,0.912012266312541
557,WP_NUCLEAR_RECEPTORS,20,Down,0.619753468304216,0.912012266312541
558,WP_IL4_SIGNALING,50,Down,0.623357513172463,0.912012266312541
559,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.624910277898563,0.912012266312541
560,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.626715513444229,0.912012266312541
561,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,19,Up,0.627536463268899,0.912012266312541
562,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.628275696692723,0.912012266312541
563,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.62858828722807,0.912012266312541
564,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.629656609048371,0.912012266312541
565,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Up,0.63103023184041,0.912012266312541
566,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Down,0.631398564065387,0.912012266312541
567,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.631400296888675,0.912012266312541
568,WP_RETINOL_METABOLISM,6,Up,0.632784750431626,0.912012266312541
569,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,10,Down,0.632860576529338,0.912012266312541
570,WP_OXIDATION_BY_CYTOCHROME_P450,15,Up,0.635981435357484,0.912012266312541
571,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.636200192085436,0.912012266312541
572,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.638247243878538,0.912012266312541
573,WP_IRON_METABOLISM_DISORDERS,10,Up,0.638811544166147,0.912012266312541
574,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Down,0.638928924769975,0.912012266312541
575,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.646327149922319,0.912012266312541
576,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.646808222583764,0.912012266312541
577,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.6478224954431,0.912012266312541
578,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.64809974848604,0.912012266312541
579,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,6,Down,0.648665812039022,0.912012266312541
580,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.649854726961393,0.912012266312541
581,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.650881997383514,0.912012266312541
582,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.652701375787962,0.912012266312541
583,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.653903859417061,0.912012266312541
584,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.654834759024008,0.912012266312541
585,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.655292957461824,0.912012266312541
586,WP_MIRNA_BIOGENESIS,6,Down,0.656491499464757,0.912012266312541
587,WP_PPAR_SIGNALING,39,Down,0.657130474483811,0.912012266312541
588,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.660152508971407,0.912012266312541
589,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.661059893837618,0.912012266312541
590,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.66146174388785,0.912012266312541
591,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,169,Down,0.663664792629124,0.912012266312541
592,WP_ASPIRIN_AND_MIRNAS,8,Down,0.664886102104176,0.912012266312541
593,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.665453780185955,0.912012266312541
594,WP_STEROID_BIOSYNTHESIS,2,Down,0.665533604579847,0.912012266312541
595,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.667547669380505,0.912012266312541
596,WP_IL9_SIGNALING,15,Down,0.667553379004827,0.912012266312541
597,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Up,0.669190645259913,0.912012266312541
598,WP_NAD_METABOLISM,11,Up,0.670370864101123,0.912012266312541
599,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Down,0.670445656393224,0.912012266312541
600,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.672119271468443,0.912012266312541
601,WP_PROLACTIN_SIGNALING,68,Up,0.672658639498257,0.912012266312541
602,WP_EICOSANOID_SYNTHESIS,13,Up,0.672851479194376,0.912012266312541
603,WP_CIRCADIAN_RHYTHM_GENES,114,Down,0.672985946455789,0.912012266312541
604,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.67378256631747,0.912012266312541
605,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.676313473560879,0.912012266312541
606,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,26,Up,0.676535572375732,0.912012266312541
607,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.677571759386042,0.912012266312541
608,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.679046461846883,0.912012266312541
609,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.679127605634893,0.912012266312541
610,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Up,0.679833761300476,0.912012266312541
611,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.680724638231633,0.912012266312541
612,WP_NONSMALL_CELL_LUNG_CANCER,57,Down,0.680907963719127,0.912012266312541
613,WP_ACUTE_MYELOID_LEUKEMIA,55,Down,0.681741983021935,0.912012266312541
614,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.683716086541018,0.912012266312541
615,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,44,Up,0.68443818033612,0.912012266312541
616,WP_PARKINSONS_DISEASE_PATHWAY,26,Up,0.684473950508219,0.912012266312541
617,WP_GASTRIC_CANCER_NETWORK_1,15,Up,0.684563951721214,0.912012266312541
618,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.688933021316882,0.914978635657546
619,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.689016758481777,0.914978635657546
620,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Up,0.695237919180501,0.921750918655439
621,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.700603203256703,0.927368491267327
622,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Up,0.702428408098011,0.928289632566824
623,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.706444932997953,0.930799015297877
624,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.707675323099653,0.930799015297877
625,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.708569774372172,0.930799015297877
626,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.708856671017604,0.930799015297877
627,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.714195847515156,0.936314173297382
628,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.715363715079031,0.93635186910026
629,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.717001300013207,0.937003288729502
630,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.719082613758709,0.938231600808982
631,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.724851860022227,0.938651528781999
632,WP_VALPROIC_ACID_PATHWAY,8,Up,0.725217453034338,0.938651528781999
633,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.728130346628905,0.938651528781999
634,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.728622577066458,0.938651528781999
635,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.728622577066458,0.938651528781999
636,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.731371691241998,0.938651528781999
637,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Up,0.731514091449394,0.938651528781999
638,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Down,0.731551986052165,0.938651528781999
639,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Down,0.732640828687856,0.938651528781999
640,WP_MALE_INFERTILITY,66,Down,0.734510902871691,0.938651528781999
641,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.736519277970064,0.938651528781999
642,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.736771526231238,0.938651528781999
643,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Up,0.737230780722708,0.938651528781999
644,WP_NEPHROTIC_SYNDROME,27,Down,0.738439103178061,0.938651528781999
645,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.738703763083248,0.938651528781999
646,WP_IL26_SIGNALING,31,Up,0.73939211254965,0.938651528781999
647,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.742504157743983,0.938651528781999
648,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.743090069155616,0.938651528781999
649,WP_AGERAGE_PATHWAY,54,Up,0.744052692363848,0.938651528781999
650,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.744872847918816,0.938651528781999
651,WP_ALZHEIMERS_DISEASE,182,Up,0.745007746047726,0.938651528781999
652,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,182,Up,0.745007746047726,0.938651528781999
653,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.745668428582293,0.938651528781999
654,WP_TGFB_SMAD_SIGNALING,7,Down,0.749967547992667,0.939091068163288
655,WP_PI3KAKT_SIGNALING,173,Down,0.750085488388317,0.939091068163288
656,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.750236185711661,0.939091068163288
657,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.750587386597665,0.939091068163288
658,WP_ENDODERM_DIFFERENTIATION,80,Down,0.754984702003211,0.941644067163943
659,WP_PDGFRBETA_PATHWAY,27,Up,0.755304206543302,0.941644067163943
660,WP_5Q35_COPY_NUMBER_VARIATION,75,Up,0.756064579474699,0.941644067163943
661,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Up,0.760939006181268,0.945709766132373
662,WP_MRNA_PROCESSING,124,Up,0.761630006301254,0.945709766132373
663,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.763233814493544,0.946271788105118
664,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Down,0.767588510048159,0.949326794510669
665,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.768007686556684,0.949326794510669
666,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.770782044229159,0.949868595250198
667,WP_TRANSSULFURATION_PATHWAY,8,Up,0.77376599994962,0.949868595250198
668,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.773970452208783,0.949868595250198
669,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Down,0.774796260796541,0.949868595250198
670,WP_ESTROGEN_SIGNALING,21,Up,0.775314544749688,0.949868595250198
671,WP_NEUROINFLAMMATION,10,Up,0.776532330257858,0.949868595250198
672,WP_TRANSLATION_FACTORS,49,Down,0.776534909985564,0.949868595250198
673,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.778595700439179,0.950974243329873
674,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.783126224655827,0.952084718040784
675,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Up,0.784582486192559,0.952084718040784
676,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Up,0.785225357520816,0.952084718040784
677,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.787234889764148,0.952084718040784
678,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,43,Up,0.78811558844601,0.952084718040784
679,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.788636992231967,0.952084718040784
680,WP_IL11_SIGNALING,40,Up,0.789171269473314,0.952084718040784
681,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,19,Down,0.789286841644957,0.952084718040784
682,WP_HEPATITIS_B_INFECTION,116,Up,0.789929169955979,0.952084718040784
683,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,35,Up,0.792660107127026,0.953431090222665
684,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.794342649832854,0.953431090222665
685,WP_BARDETBIEDL_SYNDROME,65,Down,0.794525908518887,0.953431090222665
686,WP_P38_MAPK_SIGNALING,31,Up,0.79938922171753,0.956535906222765
687,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,61,Down,0.801271269963015,0.956535906222765
688,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Down,0.801841788061261,0.956535906222765
689,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.802042134291878,0.956535906222765
690,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.80389368998485,0.956535906222765
691,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Up,0.80472587716801,0.956535906222765
692,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Down,0.805258938085345,0.956535906222765
693,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Up,0.807682172979508,0.956845393876338
694,WP_MEASLES_VIRUS_INFECTION,98,Up,0.807847570985618,0.956845393876338
695,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.810376382872374,0.957642836519194
696,WP_PURINE_METABOLISM,9,Down,0.810850868877565,0.957642836519194
697,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.814539419703333,0.960618942605653
698,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.818451083711064,0.963849270502142
699,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.823072891807882,0.967905460752616
700,WP_MAPK_CASCADE,30,Up,0.824995275812019,0.968544442044631
701,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.827043963295961,0.968544442044631
702,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.827151092841035,0.968544442044631
703,WP_PRION_DISEASE_PATHWAY,28,Up,0.829997389006609,0.97049481331925
704,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.832137445543865,0.97161502874582
705,WP_TAR_SYNDROME,43,Up,0.833607340398475,0.971950686251839
706,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.835393077348532,0.971995712690667
707,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.836306032715217,0.971995712690667
708,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.837193387572983,0.971995712690667
709,WP_THERMOGENESIS,72,Down,0.840822760679222,0.972200948008796
710,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.843493945396699,0.972200948008796
711,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.845040909850731,0.972200948008796
712,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.845307485829394,0.972200948008796
713,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.845581249418888,0.972200948008796
714,WP_SEROTONIN_AND_ANXIETY,7,Up,0.845961372802389,0.972200948008796
715,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.847449419767226,0.972200948008796
716,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Down,0.848387858156411,0.972200948008796
717,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.851098326574849,0.972200948008796
718,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.85114421636535,0.972200948008796
719,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Up,0.852870252500401,0.972200948008796
720,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.853354793307874,0.972200948008796
721,WP_PREIMPLANTATION_EMBRYO,20,Down,0.854129088564546,0.972200948008796
722,WP_ADIPOGENESIS,84,Up,0.854518981721829,0.972200948008796
723,WP_IDO_METABOLIC_PATHWAY,7,Down,0.858262746231551,0.972200948008796
724,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.858363599448403,0.972200948008796
725,WP_DRAVET_SYNDROME,12,Down,0.858893546272662,0.972200948008796
726,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.859317137307178,0.972200948008796
727,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.860414731029633,0.972200948008796
728,WP_16P112_DISTAL_DELETION_SYNDROME,20,Down,0.861938127614668,0.972200948008796
729,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.864348127613877,0.972200948008796
730,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.864964062847562,0.972200948008796
731,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.865987395224259,0.972200948008796
732,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.866933786736054,0.972200948008796
733,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.867697397551414,0.972200948008796
734,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.868121041166006,0.972200948008796
735,WP_CHEMOKINE_SIGNALING,107,Down,0.873506263872874,0.976900882861908
736,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Up,0.880351524597352,0.982530637557796
737,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.884062714595351,0.982530637557796
738,WP_CHOLESTEROL_METABOLISM,52,Up,0.885153141840293,0.982530637557796
739,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.885292016801408,0.982530637557796
740,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.886525045550071,0.982530637557796
741,WP_DNA_REPLICATION,35,Up,0.890390917882006,0.982530637557796
742,WP_CILIOPATHIES,125,Up,0.891527624482041,0.982530637557796
743,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Up,0.892965889655938,0.982530637557796
744,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.893831832195163,0.982530637557796
745,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,41,Down,0.89423299862901,0.982530637557796
746,WP_BASE_EXCISION_REPAIR,29,Down,0.897045240875684,0.982530637557796
747,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Up,0.898235612779876,0.982530637557796
748,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.900294955451991,0.982530637557796
749,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.901007983446612,0.982530637557796
750,WP_HIPPO_SIGNALING_REGULATION,44,Up,0.904234172427029,0.982530637557796
751,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.905024564890339,0.982530637557796
752,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.905776075598585,0.982530637557796
753,WP_ONCOSTATIN_M_SIGNALING,55,Up,0.90960953746632,0.982530637557796
754,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.910866419809456,0.982530637557796
755,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.910986003483627,0.982530637557796
756,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.912757965955921,0.982530637557796
757,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.91283669725208,0.982530637557796
758,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.913192865044415,0.982530637557796
759,WP_CANCER_PATHWAYS,295,Up,0.913953235797287,0.982530637557796
760,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.914672697785043,0.982530637557796
761,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.916465138342934,0.982530637557796
762,WP_MELANOMA,52,Down,0.916673484095187,0.982530637557796
763,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.917912668887219,0.982530637557796
764,WP_NOTCH_SIGNALING_WP61,48,Down,0.918366380518294,0.982530637557796
765,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.919807763022066,0.982530637557796
766,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Up,0.920534811653922,0.982530637557796
767,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.921069182324817,0.982530637557796
768,WP_PLEURAL_MESOTHELIOMA,245,Down,0.921277951869304,0.982530637557796
769,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.922129365685834,0.982530637557796
770,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,14,Up,0.922201710001895,0.982530637557796
771,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.922476627903624,0.982530637557796
772,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.922766000236762,0.982530637557796
773,WP_IL18_SIGNALING,186,Up,0.925401524171977,0.984062164125957
774,WP_NRXN1_DELETION_SYNDROME,2,Down,0.928270382004674,0.985837537477832
775,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.930742859349398,0.987187910174459
776,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.935880669160913,0.98738426627272
777,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Down,0.939873310709969,0.98738426627272
778,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Up,0.942700723353705,0.98738426627272
779,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.942781437460235,0.98738426627272
780,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.943616904408331,0.98738426627272
781,WP_TOLLLIKE_RECEPTOR_SIGNALING,78,Up,0.944084816289525,0.98738426627272
782,WP_CELLULAR_PROTEOSTASIS,6,Up,0.944905213665848,0.98738426627272
783,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.946037908471645,0.98738426627272
784,WP_FOLATE_METABOLISM,36,Up,0.946269117926671,0.98738426627272
785,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.948757429935097,0.98738426627272
786,WP_FRAGILE_X_SYNDROME,83,Up,0.948862377037855,0.98738426627272
787,WP_ALLOGRAFT_REJECTION,48,Down,0.948909790134901,0.98738426627272
788,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.954373085509097,0.98738426627272
789,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Down,0.95490992129927,0.98738426627272
790,WP_KALLMANN_SYNDROME,11,Down,0.955999652391867,0.98738426627272
791,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,77,Up,0.95685642528913,0.98738426627272
792,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.957287568864517,0.98738426627272
793,WP_G_PROTEIN_SIGNALING,61,Down,0.957919618684343,0.98738426627272
794,WP_LUNG_PATHOLOGY_OF_COVID19,13,Up,0.958876993666869,0.98738426627272
795,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,6,Down,0.959109977982315,0.98738426627272
796,WP_WNT_SIGNALING_WP428,58,Down,0.959148698405053,0.98738426627272
797,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.959885821064216,0.98738426627272
798,WP_IL3_SIGNALING,46,Up,0.960894524919538,0.98738426627272
799,WP_FOXP3_IN_COVID19,9,Up,0.961705424050926,0.98738426627272
800,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.962438789987747,0.98738426627272
801,WP_NETRINUNC5B_SIGNALING,35,Up,0.962868292129031,0.98738426627272
802,WP_ID_SIGNALING,12,Up,0.963722953187188,0.98738426627272
803,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.964561515592451,0.98738426627272
804,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.969925900951085,0.990045756208006
805,WP_IL2_SIGNALING,37,Down,0.969943388943987,0.990045756208006
806,WP_MONOAMINE_TRANSPORT,11,Up,0.971110914363808,0.990045756208006
807,WP_COPPER_HOMEOSTASIS,39,Down,0.972721318247188,0.990045756208006
808,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.97318366303658,0.990045756208006
809,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.976271444479591,0.990103259528365
810,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.976288140979558,0.990103259528365
811,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,42,Down,0.978566491973623,0.990103259528365
812,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.979262712891193,0.990103259528365
813,WP_HEME_BIOSYNTHESIS,8,Up,0.979262712891193,0.990103259528365
814,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Down,0.986654851920387,0.993981621703723
815,WP_PEPTIDE_GPCRS,13,Down,0.986701424277816,0.993981621703723
816,WP_ATM_SIGNALING,34,Down,0.986726281399317,0.993981621703723
817,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.988509596147256,0.994559226478634
818,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Up,0.990753116986041,0.994632957333508
819,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Down,0.99100291004397,0.994632957333508
820,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.994566668142961,0.996992440504285
821,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.997333338133671,0.99854811686465
822,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Down,0.999522374600332,0.999522374600332
